Literature DB >> 4045913

Comparison of different endocrine therapies in management of bone metastases from breast carcinoma.

I E Smith, V Macaulay.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4045913      PMCID: PMC1289528     

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  16 in total

1.  Results of hypophysectomy in the treatment of metastatic mammary carcinoma.

Authors:  O H PEARSON; B S RAY
Journal:  Cancer       Date:  1959 Jan-Feb       Impact factor: 6.860

2.  Hypophysectomy as compared with adrenalectomy in the treatment of advanced carcinoma of the breast.

Authors:  A A Fracchia; J H Farrow; T R Miller; R H Tollefsen; E J Greenberg; W H Knapper
Journal:  Surg Gynecol Obstet       Date:  1971-08

3.  Castration for primary inoperable or recurrent breast carcinoma.

Authors:  A A Fracchia; J H Farrow; A J DePalo; D P Connolly; A G Huvos
Journal:  Surg Gynecol Obstet       Date:  1969-06

4.  Combination treatment with tamoxifen and aminoglutethimide in advanced breast cancer.

Authors:  I E Smith; A L Harris; R Stuart-Harris; H T Ford; J C Gazet; H White; C L Harmer; L Carr; J A McKinna; M Morgan
Journal:  Br Med J (Clin Res Ed)       Date:  1983-05-21

5.  Randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer.

Authors:  A Lipton; H A Harvey; R J Santen; A Boucher; D White; A Bernath; R Dixon; G Richards; A Shafik
Journal:  Cancer Res       Date:  1982-08       Impact factor: 12.701

6.  Hormonal treatment of disseminated cancer of the female breast.

Authors:  G S GORDAN; W P GRAHAM; L GOLDMAN; R PAPAC; G E SHELINE; J VAETH; J WITT
Journal:  Calif Med       Date:  1963-04

7.  Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial.

Authors:  I E Smith; A L Harris; M Morgan; H T Ford; J C Gazet; C L Harmer; H White; C A Parsons; A Villardo; G Walsh; J A McKinna
Journal:  Br Med J (Clin Res Ed)       Date:  1981-11-28

8.  Progestin therapy in advanced breast cancer: megestrol acetate--an evaluation of 160 treated cases.

Authors:  J Alexieva-Figusch; H A van Gilse; W C Hop; C H Phoa; J Blonk-van der Wijst; R E Treurniet
Journal:  Cancer       Date:  1980-12-01       Impact factor: 6.860

9.  A randomized trial comparing surgical adrenalectomy with aminoglutethimide plus hydrocortisone in women with advanced breast cancer.

Authors:  R J Santen; T J Worgul; E Samojlik; A Interrante; A E Boucher; A Lipton; H A Harvey; D S White; E Smart; C Cox; S A Wells
Journal:  N Engl J Med       Date:  1981-09-03       Impact factor: 91.245

10.  An evaluation of high-dose medroxyprogesterone acetate (MPA) therapy in women with advanced breast cancer.

Authors:  J R Johnson; T J Priestman; K Fotherby; K A Kelly; S G Priestman
Journal:  Br J Cancer       Date:  1984-09       Impact factor: 7.640

View more
  2 in total

1.  Treating bony metastases.

Authors:  D Dodwell; A Howell
Journal:  BMJ       Date:  1991-08-24

Review 2.  Tamoxifen. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.

Authors:  M M Buckley; K L Goa
Journal:  Drugs       Date:  1989-04       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.